Major bleeding risk in anticoagulated patients receiving concomitant antiplatelet therapy: a prospective study

Donzé, Jacques; Rodondi, Nicolas; Waeber, Gérard; Cornuz, Jacques; Aujesky, Drahomir (2013). Major bleeding risk in anticoagulated patients receiving concomitant antiplatelet therapy: a prospective study. Thrombosis research, 131(6), pp. 502-507. Elsevier 10.1016/j.thromres.2013.04.033

Text Donzé, Rodondi, Thrombosis Research 2013.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (261kB)

INTRODUCTION

Current literature suggesting a higher bleeding risk during combination therapy compared to oral anticoagulation alone is primarily based on retrospective studies or specific populations. We aimed to prospectively evaluate whether unselected medical patients on oral anticoagulation have an increased risk of bleeding when on concomitant antiplatelet therapy.

MATERIAL AND METHODS

We prospectively studied consecutive adult medical patients who were discharged on oral anticoagulants between 01/2008 and 03/2009 from a Swiss university hospital. The primary outcome was the time to a first major bleed on oral anticoagulation within 12 months, adjusted for age, international normalized ratio target, number of medications, and history of myocardial infarction and major bleeding.

RESULTS

Among the 515 included anticoagulated patients, the incidence rate of a first major bleed was 8.2 per 100 patient-years. Overall, 161 patients (31.3%) were on both anticoagulant and antiplatelet therapy, and these patients had a similar incidence rate of major bleeding compared to patients on oral anticoagulation alone (7.6 vs. 8.4 per 100 patient-years, P=0.81). In a multivariate analysis, the association of concomitant antiplatelet therapy with the risk of major bleeding was not statistically significant (hazard ratio 0.89, 95% confidence interval, 0.37-2.10).

CONCLUSIONS

The risk of bleeding in patients receiving oral anticoagulants combined with antiplatelet therapy was similar to patients receiving oral anticoagulants alone, suggesting that the incremental bleeding risk of combination therapy might not be clinically significant.

Interest & Impact

Downloads

1 since deposited on 25 Feb 2014
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item